Atlas Trials

Study of GPX-100 in the Treatment of Metastatic Breast Cancer

Clinical trial NCT00123877 · TERMINATED

Trial details

NCT number
NCT00123877
Sponsor
Gem Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerMetastasis
Start date
2005-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.